4.6 Review

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies

期刊

BRITISH JOURNAL OF PSYCHIATRY
卷 202, 期 5, 页码 329-335

出版社

ROYAL COLLEGE OF PSYCHIATRISTS
DOI: 10.1192/bjp.bp.112.118307

关键词

-

资金

  1. John Hartford Foundation
  2. UPMC Endowment in Geriatric Psychiatry, National Institute of Health [R01 MH072947, R01 MH080240, P30 MH090333, UL1 RR024153, UL1TR000005]
  3. John A. Hartford Foundation
  4. National Institute of Mental Health (NIMH) and National Institute on Aging (NIA)
  5. NIMH, NIA, National Center for Minority Health Disparities (NIMHD), National Heart Lung and Blood Institute (NHLBI), Center for Medicare and Medicaid Services
  6. American Foundation for Suicide Prevention
  7. Commonwealth of Pennsylvania

向作者/读者索取更多资源

Background Late-life depression may increase the risk of incident dementia, in particular of Alzheimer's disease and vascular dementia. Aims To conduct a systematic review and meta-analysis to evaluate the risk of incident all-cause dementia, Alzheimer's disease and vascular dementia in individuals with late-life depression in population-based prospective studies. Method A total of 23 studies were included in the meta-analysis. We used the generic inverse variance method with a random-effects model to calculate the pooled risk of dementia, Alzheimer's disease and vascular dementia in older adults with late-life depression. Results Late-life depression was associated with a significant risk of all-cause dementia (1.85, 95% CI 1.67-2.04, P<0.001), Alzheimer's disease (1.65, 95% CI 1.42-1.92, P<0.001) and vascular dementia (2.52, 95% CI 1.77-3.59, P<0.001). Subgroup analysis, based on five studies, showed that the risk of vascular dementia was significantly higher than for Alzheimer's disease (P = 0.03). Conclusions Late-life depression is associated with an increased risk for all-cause dementia, vascular dementia and Alzheimer's disease. The present results suggest that it will be valuable to design clinical trials to investigate the effect of late-life depression prevention on risk of dementia, in particular vascular dementia and Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据